The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...

ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...

Leucine Rich Bio with Micro Health Labs to launch BugSpeaks in Qatar, pioneering gut microbiome test globally: Our Bureau, Bengaluru Friday, May 9, 2025, 15:45 Hrs [IST] Leucine R ...

Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Ginkgo Bioworks, which is building the leading platform for ...

Govt of Telangana appoints Shahnawaz Qasim, director general of the drug control administration ...

CASI Pharma receives notice from Nasdaq regarding minimum market value requirement: Beijing, China Friday, May 9, 2025, 13:30 Hrs [IST] CASI Pharmaceuticals, Inc, a biopharmaceuti ...

HLS Therapeutics partners with Esperion Therapeutics to commercialize Nexletol and Nexlizet in Canada: Toronto Friday, May 9, 2025, 14:00 Hrs [IST] HLS Therapeutics Inc. (HLS), a ...

FY25 revenue at Rs. 4,454 crore up by 15%, net profit at Rs 344 crore: Our Bureau, Bengaluru Friday, May 9, 2025, 12:30 Hrs [IST] Biocon in its consolidated financial re ...

Major mass photometry milestone achieved by Refeyn with installation of 500 system globally: Oxford, UK Friday, May 9, 2025, 13:00 Hrs [IST] Refeyn, the company behind pioneering ...

GeneFab, RegCell partner to advance autoimmune cell therapy into US clinical trials: Alameda, California Friday, May 9, 2025, 12:00 Hrs [IST] GeneFab, a next-generation cell and g ...

More patients in the linerixibat group had clinically meaningful itch improvement (WI-NRS =3-point reduction) with 56% versus 43% in the placebo group at week 24 (treatment difference 13% [95% CI ...